PreprintAll rights reservedmedRxiv
Longitudinal interferon signatures are associated with disease flare in dermatomyositis
- 1Lady Davis Institute for Medical Research, Montreal, Canada
Related
- Staged multi-target therapy for anti-MDA5-positive dermatomyositis-associated rapidly progressive interstitial lung disease: a case report.
- Candidate molecular endotypes and dynamic risk prediction in anti-MDA5-positive dermatomyositis-associated interstitial lung disease: a systematic scoping review
- Development of siRNAs targeting interferon beta as a novel therapeutic approach for adult and juvenile dermatomyositis
- Serum Interferon Gamma-induced Protein 10 Levels in Patients with Type 2 Diabetes and Metabolic Dysfunction-associated Steatotic Liver Disease: A Case-control Study.
- Systemic Immune-Inflammation Index (SII) correlates with disease activity but not with interferon-associated chemokines in SLE
BibTeX
@misc{liu2026longitudinal,
title = {{Longitudinal interferon signatures are associated with disease flare in dermatomyositis}},
author = {P. Liu and H. Chou and M. Jarry and M. Hudson and S. V. del Rincon and P. Lefrancois and V. Leclair},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.15.26362919},
url = {https://www.medrxiv.org/content/10.64898/2026.09.15.26362919v1},
}
RIS
TY - UNPB
TI - Longitudinal interferon signatures are associated with disease flare in dermatomyositis
AU - P. Liu
AU - H. Chou
AU - M. Jarry
AU - M. Hudson
AU - S. V. del Rincon
AU - P. Lefrancois
AU - V. Leclair
PY - 2026
DA - 2026/09/15
PB - medRxiv
DO - 10.64898/2026.09.15.26362919
UR - https://www.medrxiv.org/content/10.64898/2026.09.15.26362919v1
ER -